These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 17416791)

  • 1. Ferritin and transferrin are associated with metabolic syndrome abnormalities and their change over time in a general population: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).
    Vari IS; Balkau B; Kettaneh A; André P; Tichet J; Fumeron F; Caces E; Marre M; Grandchamp B; Ducimetière P;
    Diabetes Care; 2007 Jul; 30(7):1795-801. PubMed ID: 17416791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferritin and transferrin are both predictive of the onset of hyperglycemia in men and women over 3 years: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study.
    Fumeron F; Péan F; Driss F; Balkau B; Tichet J; Marre M; Grandchamp B;
    Diabetes Care; 2006 Sep; 29(9):2090-4. PubMed ID: 16936158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged men and women: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort.
    André P; Balkau B; Vol S; Charles MA; Eschwège E;
    Diabetes Care; 2007 Sep; 30(9):2355-61. PubMed ID: 17586745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study.
    Bener A; Zirie M; Musallam M; Khader YS; Al-Hamaq AO
    Metab Syndr Relat Disord; 2009 Jun; 7(3):221-9. PubMed ID: 19320557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study.
    Hildrum B; Mykletun A; Hole T; Midthjell K; Dahl AA
    BMC Public Health; 2007 Aug; 7():220. PubMed ID: 17727697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors accounting for high ferritin levels in obesity.
    Lecube A; Hernández C; Pelegrí D; Simó R
    Int J Obes (Lond); 2008 Nov; 32(11):1665-9. PubMed ID: 18779821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of serum ferritin with metabolic syndrome and diabetes mellitus in the South Korean general population according to the Korean National Health and Nutrition Examination Survey 2008.
    Lee BK; Kim Y; Kim YI
    Metabolism; 2011 Oct; 60(10):1416-24. PubMed ID: 21489582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.
    Xu A; Tso AW; Cheung BM; Wang Y; Wat NM; Fong CH; Yeung DC; Janus ED; Sham PC; Lam KS
    Circulation; 2007 Mar; 115(12):1537-43. PubMed ID: 17389279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
    Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
    Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body iron stores in relation to the metabolic syndrome, glycemic control and complications in female patients with type 2 diabetes.
    Mojiminiyi OA; Marouf R; Abdella NA
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):559-66. PubMed ID: 18063352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the new international diabetes federation definition of metabolic syndrome to WHO and NCEP definitions in Chinese, European and South Asian origin adults.
    Unwin N; Bhopal R; Hayes L; White M; Patel S; Ragoobirsingh D; Alberti G
    Ethn Dis; 2007; 17(3):522-8. PubMed ID: 17985508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population.
    Choi KM; Kim SM; Kim YE; Choi DS; Baik SH; Lee J;
    Metabolism; 2007 Apr; 56(4):552-8. PubMed ID: 17379016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All-cause mortality associated with specific combinations of the metabolic syndrome according to recent definitions.
    Guize L; Thomas F; Pannier B; Bean K; Jego B; Benetos A
    Diabetes Care; 2007 Sep; 30(9):2381-7. PubMed ID: 17563336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is a unified definition of metabolic syndrome needed? Comparison of three definitions of metabolic syndrome in 60-year-old men and women.
    Carlsson AC; Wändell PE; Halldin M; de Faire U; Hellénius ML
    Metab Syndr Relat Disord; 2009 Jun; 7(3):231-41. PubMed ID: 19284315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum ferritin levels are associated with metabolic syndrome in postmenopausal women but not in premenopausal women.
    Cho GJ; Shin JH; Yi KW; Park HT; Kim T; Hur JY; Kim SH
    Menopause; 2011 Oct; 18(10):1120-4. PubMed ID: 21694651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association among serum ferritin, alanine aminotransferase levels, and metabolic syndrome in Korean postmenopausal women.
    Choi KM; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH
    Metabolism; 2005 Nov; 54(11):1510-4. PubMed ID: 16253641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
    Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
    de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
    Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome and incident end-stage peripheral vascular disease: a 14-year follow-up study in elderly Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Diabetes Care; 2007 Dec; 30(12):3099-104. PubMed ID: 17848614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of apolipoprotein-B/apolipoprotein-AI in subjects with versus without the metabolic syndrome.
    Sierra-Johnson J; Somers VK; Kuniyoshi FH; Garza CA; Isley WL; Gami AS; Lopez-Jimenez F
    Am J Cardiol; 2006 Nov; 98(10):1369-73. PubMed ID: 17134631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.